PharmaVigilant Founder and Chief Executive Officer Wins International Clinical Research Award
5/10/2011 10:15:50 AM
WESTBOROUGH, Mass.--(BUSINESS WIRE)--PharmaVigilant, a provider of integrated clinical trial software solutions, announced today that its CEO, James DeSanti, has been awarded the 2011 Innovation in Clinical Research Award from the Association of Clinical Research Professionals (ACRP). DeSanti was recognized Monday, May 2 at the ACRP 2011 Global Conference in Seattle, Washington for his professional achievements in the clinical research field. ACRP is a global association comprised of more than 20,000 individuals in over 60 countries dedicated to clinical research and development.
comments powered by